ABIOGEN PHARMA SpA

Discover ABIOGEN PHARMA SpA: Italian Pharmaceutical Innovation

ABIOGEN PHARMA SpA is an Italian pharmaceutical company based in Pisa, founded in 1997. With over a century of experience, it has established itself as a reference point for the medical community, specializing in therapeutic areas such as bone metabolism, vitamin D deficiency, pain, viscosupplementation, dermatology, respiratory, and diabetology. Its history is characterized by constant passion, scientific research, technological innovation, and openness to internationalization.

Cutting-edge research and development

ABIOGEN PHARMA SpA invests significantly in research and development, with particular focus on bone metabolism, pain management, and respiratory and metabolic diseases, including diabetes. The company acquired EffRx Pharmaceuticals SA, a Swiss company active in the development and sales of drugs for musculoskeletal and rare diseases, present in 24 European and non-European markets. Additionally, it has launched the "sterile 2" project, with an investment of 50 million euros for the creation of a second sterile department in the Pisa facility, thus doubling production capacity.

Product range and awards

ABIOGEN PHARMA SpA offers a wide range of products, including medicines, medical devices, supplements, and foods for special medical purposes, to meet therapeutic needs in various areas. The company has obtained ISO 9001:2015 certification, which ensures a strategic approach to the quality system, guaranteeing the optimization of production resources and the continuous improvement of products and services. Furthermore, it has been recognized as one of "Italy's Best Employers" in the Forbes ranking, highlighting excellence in the Italian pharmaceutical sector.